Related references
Note: Only part of the references are listed.Hyaluronic acid-bilirubin nanomedicine for targeted modulation of dysregulated intestinal barrier, microbiome and immune responses in colitis
Yonghyun Lee et al.
NATURE MATERIALS (2020)
Chitosan-modified lipid nanodrug delivery system for the targeted and responsive treatment of ulcerative colitis
Shao-qing Chen et al.
CARBOHYDRATE POLYMERS (2020)
Can naturally occurring nanoparticle-based targeted drug delivery effectively treat inflammatory bowel disease?
Chunhua Yang et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative Colitis
William J. Sandborn et al.
GASTROENTEROLOGY (2020)
ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment
Joana Torres et al.
JOURNAL OF CROHNS & COLITIS (2020)
Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 Study
Bruce E. Sands et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Lycium barbarum lipid-based edible nanoparticles protect against experimental colitis
Menghang Zu et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
JAK Inhibitors Safety in Ulcerative Colitis: Practical Implications
Manasi Agrawal et al.
JOURNAL OF CROHNS & COLITIS (2020)
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
Xiao Yan Guo et al.
JOURNAL OF DIGESTIVE DISEASES (2020)
Strategic Approaches for Colon Targeted Drug Delivery: An Overview of Recent Advancements
Sang Hoon Lee et al.
PHARMACEUTICS (2020)
Gut-on-a-chip: Current progress and future opportunities
Nureddin Ashammakhi et al.
BIOMATERIALS (2020)
Site-specific targeted drug delivery systems for the treatment of inflammatory bowel disease
Xin Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Microbial therapeutics for acute colitis based on genetically modifiedLactococcus lactishypersecreting IL-1Ra in mice
Fu Namai et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Colonic delivery of vasoactive intestinal peptide nanomedicine alleviates colitis and shows promise as an oral capsule
Dulari Jayawardena et al.
NANOMEDICINE (2020)
Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model
Jung Min Kim et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Recent advances in colon drug delivery systems
Roberto Arevalo-Perez et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Oral delivery of anti-TNF antibody shielded by natural polyphenol-mediated supramolecular assembly for inflammatory bowel disease therapy
Xinyu Wang et al.
THERANOSTICS (2020)
Intestinal Organoids as a Tool for Inflammatory Bowel Disease Research
Hamish C. K. Angus et al.
FRONTIERS IN MEDICINE (2020)
Biological therapies in inflammatory bowel disease: Beyond anti-TNF therapies
Konstantinos H. Katsanos et al.
CLINICAL IMMUNOLOGY (2019)
Orally Delivered Antisense Oligodeoxyribonucleotides of TNF-α via Polysaccharide-Based Nanocomposites Targeting Intestinal Inflammation
Bingchao Duan et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease
Davide Di Fusco et al.
FRONTIERS IN PHARMACOLOGY (2019)
Development of oral foams for topical treatment of inflammatory bowel disease
Dorota Haznar-Garbacz et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Self-organization and symmetry breaking in intestinal organoid development
Denise Serra et al.
NATURE (2019)
Oligonucleotides-A Novel Promising Therapeutic Option for IBD
Patrizio Scarozza et al.
FRONTIERS IN PHARMACOLOGY (2019)
Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice
Maria Jose Chiabai et al.
BMC BIOTECHNOLOGY (2019)
Human-gut-microbiome on a chip
Roberta Poceviciute et al.
NATURE BIOMEDICAL ENGINEERING (2019)
Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
Nicholas A. Kennedy et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
Christopher Andrew Lamb et al.
GUT (2019)
Phospholipid-Free Small Unilamellar Vesicles for Drug Targeting to Cells in the Liver
Wunan Zhang et al.
SMALL (2019)
A Proresolving Peptide Nanotherapy for Site-Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut Microbiota
Chenwen Li et al.
ADVANCED SCIENCE (2019)
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
Israr Khan et al.
PATHOGENS (2019)
Oral Anti-Tumour Necrosis Factor Domain Antibody V565 Provides High Intestinal Concentrations, and Reduces Markers of Inflammation in Ulcerative Colitis Patients
Suhail Nurbhai et al.
SCIENTIFIC REPORTS (2019)
Therapeutic Oligonucleotides: State of the Art
C. I. Edvard Smith et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Oral delivery of the anti-tumor necrosis factor α domain antibody, V565, results in high intestinal and fecal concentrations with minimal systemic exposure in cynomolgus monkeys
J. Scott Crowe et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2019)
AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis
Cynthia W. Ko et al.
GASTROENTEROLOGY (2019)
Non-invasive delivery strategies for biologics
Aaron C. Anselmo et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Environmental triggers in IBD: a review of progress and evidence
Ashwin N. Ananthakrishnan et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
ACG Clinical Guideline: Management of Crohn's Disease in Adults
Gary R. Lichtenstein et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Jolene L. Lau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Redox-sensitive nanoparticles based on 4-aminothiophenol-carboxymethyl inulin conjugate for budesonide delivery in inflammatory bowel diseases
Qijuan Sun et al.
CARBOHYDRATE POLYMERS (2018)
Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery
Driton Vllasaliu et al.
EXPERT OPINION ON DRUG DELIVERY (2018)
pH-triggered surface charge-reversal nanoparticles alleviate experimental murine colitis via selective accumulation in inflamed colon regions
Muhammad Naeem et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Novel peptide inhibitor of dipeptidyl peptidase IV (Tyr-Pro-D-Ala-NH2) with anti-inflammatory activity in the mouse models of colitis
M. Salaga et al.
PEPTIDES (2018)
Preclinical Development of a Novel, Orally-Administered Anti-Tumour Necrosis Factor Domain Antibody for the Treatment of Inflammatory Bowel Disease
J. Scott Crowe et al.
SCIENTIFIC REPORTS (2018)
Golimumab induction and maintenance for moderate to severe ulcerative colitis: results from GO-COLITIS (Golimumab: a Phase 4, UK, open label, single arm study on its utilization and impact in ulcerative Colitis)
Christopher S. J. Probert et al.
BMJ OPEN GASTROENTEROLOGY (2018)
A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease
Ryan McKay et al.
BIOENGINEERING & TRANSLATIONAL MEDICINE (2018)
Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis
E. J. Mao et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Alicaforsen for the treatment of inflammatory bowel disease
Vipul Jairath et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease
Qingdong Guan et al.
MEDIATORS OF INFLAMMATION (2017)
Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis
Bo Xiao et al.
MOLECULAR THERAPY (2017)
Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis
Mingzhen Zhang et al.
NANOMEDICINE (2017)
Anti-Adhesion Therapies in inflammatory Bowel Disease-Molecular and Clinical Aspects
Sebastian Zundler et al.
FRONTIERS IN IMMUNOLOGY (2017)
Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials
A. Cholapranee et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping
Balmiki Kumar et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2017)
Adeno-associated viral vectors for the treatment of hemophilia
Katherine A. High et al.
HUMAN MOLECULAR GENETICS (2016)
Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip
Hyun Jung Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Bioengineered and biohybrid bacteria-based systems for drug delivery
Zeinab Hosseinidoust et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Jung Soo Suk et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Enzyme- and pH-Responsive Microencapsulated Nanogels for Oral Delivery of siRNA to Induce TNF-α Knockdown in the Intestine
Jennifer M. Knipe et al.
BIOMACROMOLECULES (2016)
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
Mingzhen Zhang et al.
BIOMATERIALS (2016)
Targeting Inflammatory Bowel Diseases by Nanocarriers Loaded with Small and Biopharmaceutical Anti-Inflammatory Drugs
Ana Beloqui et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Applications of lipid nanoparticles in gene therapy
Ana del Pozo-Rodriguez et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2016)
AVX-470, an Orally Delivered Anti-Tumour Necrosis Factor Antibody for Treatment of Active Ulcerative Colitis: Results of a First-in-Human Trial
M. Scott Harris et al.
JOURNAL OF CROHNS & COLITIS (2016)
Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease
Alon D. Levin et al.
JOURNAL OF CROHNS & COLITIS (2016)
Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Critical Role of PepT1 in Promoting Colitis-Associated Cancer and Therapeutic Benefits of the Anti-inflammatory PepT1-Mediated Tripeptide KPV in a Murine Model
Emilie Viennois et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2016)
Of microneedles and ultrasound: Physical modes of gastrointestinal macromolecule delivery
Carl M. Schoellhammer et al.
TISSUE BARRIERS (2016)
Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis
Johannan F. Brandse et al.
GASTROENTEROLOGY (2015)
Microneedles for Drug Delivery via the Gastrointestinal Tract
Giovanni Traverso et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: Selective targeting to diseased versus healthy tissue
Susan Hua et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Cloning and variation of ground state intestinal stem cells
Xia Wang et al.
NATURE (2015)
Biologic agents for IBD: practical insights
Silvio Danese et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer
Suniti Misra et al.
FRONTIERS IN IMMUNOLOGY (2015)
Treatment of IBD: Where We Are and Where We Are Going
Charles N. Bernstein
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Mucosal gene therapy using a pseudotyped lentivirus vector encoding murine interleukin-10 (mIL-10) suppresses the development and relapse of experimental murine colitis
Hiroshi Matsumoto et al.
BMC GASTROENTEROLOGY (2014)
Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
pH-sensitive nanoparticles for colonic delivery of curcumin in inflammatory bowel disease
Ana Beloqui et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Lectin-decorated nanoparticles enhance binding to the inflamed tissue in experimental colitis
Brice Moulari et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Targeting Intestinal Inflammation With CD98 siRNA/PEI-loaded Nanoparticles
Hamed Laroui et al.
MOLECULAR THERAPY (2014)
Oral Delivery of Glucagon Like Peptide-1 by a Recombinant Lactococcus lactis
Payal Agarwal et al.
PHARMACEUTICAL RESEARCH (2014)
Inflammatory bowel disease: Pathogenesis
Yi-Zhen Zhang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Cytokines in inflammatory bowel disease
Markus F. Neurath
NATURE REVIEWS IMMUNOLOGY (2014)
Nanoparticles for oral delivery: Targeted nanoparticles with peptidic ligands for oral protein delivery
Yeonhee Yun et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Galactosylated trimethyl chitosan-cysteine nanoparticles loaded with Map4k4 siRNA for targeting activated macrophages
Jing Zhang et al.
BIOMATERIALS (2013)
Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
Shinya Ashizuka et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2013)
Mucoadhesive intestinal devices for oral delivery of salmon calcitonin
Vivek Gupta et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Grape Exosome-like Nanoparticles Induce Intestinal Stem Cells and Protect Mice From DSS-Induced Colitis
Songwen Ju et al.
MOLECULAR THERAPY (2013)
Delivery materials for siRNA therapeutics
Rosemary Kanasty et al.
NATURE MATERIALS (2013)
Tumor Necrosis Factor Inhibitors for Inflammatory Bowel Disease
Ole Haagen Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Liposome: classification, preparation, and applications
Abolfazl Akbarzadeh et al.
NANOSCALE RESEARCH LETTERS (2013)
The immune-stimulating peptide WKYMVm has therapeutic effects against ulcerative colitis
Sang Doo Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2013)
An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice
Long Binh Vong et al.
GASTROENTEROLOGY (2012)
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
Natalie A. Molodecky et al.
GASTROENTEROLOGY (2012)
Differential MicroRNA expression tracks neoplastic progression in inflammatory bowel disease-associated colorectal cancer
Ziad Kanaan et al.
HUMAN MUTATION (2012)
Regulatory macrophages induced by infliximab are involved in healing in vivo and in vitro
Anne Christine W. Vos et al.
INFLAMMATORY BOWEL DISEASES (2012)
Polymersomes for drug delivery: Design, formation and characterization
Jung Seok Lee et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Inflammatory bowel disease in Asia: A systematic review
Lani Prideaux et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
RNA therapeutics: beyond RNA interference and antisense oligonucleotides
Ryszard Kole et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
VIP in Inflammatory Bowel Disease: State of the Art
Catalina Abad et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2012)
Review article: loss of response to anti-TNF treatments in Crohn's disease
S. Ben-Horin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Salmonella-mediated gene therapy in experimental colitis in mice
Roland Palffy et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Anti-Tumor Necrosis Factor-alpha Antibodies Induce Regulatory Macrophages in an Fc Region-Dependent Manner
Anne Christine W. Vos et al.
GASTROENTEROLOGY (2011)
Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in Mice
Hon Wai Koon et al.
GASTROENTEROLOGY (2011)
Genetics of Ulcerative Colitis
Alexandra I. Thompson et al.
INFLAMMATORY BOWEL DISEASES (2011)
Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease
Christina Kriegel et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Genetics and pathogenesis of inflammatory bowel disease
Bernard Khor et al.
NATURE (2011)
Dual TNF-α/Cyclin D1 Gene Silencing With an Oral Polymeric Microparticle System as a Novel Strategy for the Treatment of Inflammatory Bowel Disease
Christina Kriegel et al.
Clinical and Translational Gastroenterology (2011)
Delivery of siRNA Therapeutics: Barriers and Carriers
Jie Wang et al.
AAPS JOURNAL (2010)
Drug targeting strategies for the treatment of inflammatory bowel disease: a mechanistic update
Arik Dahan et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Drug-Loaded Nanoparticles Targeted to the Colon With Polysaccharide Hydrogel Reduce Colitis in a Mouse Model
Hamed Laroui et al.
GASTROENTEROLOGY (2010)
Polymers for Colon Targeted Drug Delivery
H. Rajpurohit et al.
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Neuroinflammation in inflammatory bowel disease
Shaheen E. Lakhan et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis
K. Vandenbroucke et al.
MUCOSAL IMMUNOLOGY (2010)
Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines
D. Scott Wilson et al.
NATURE MATERIALS (2010)
Lipid-based systemic delivery of siRNA
Yu-Cheng Tseng et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Nonviral vector-mediated RNA interference: Its gene silencing characteristics and important factors to achieve RNAi-based gene therapy
Yuki Takahashi et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Biological Therapies for Inflammatory Bowel Diseases
Paul Rutgeerts et al.
GASTROENTEROLOGY (2009)
Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation
Myriam Aouadi et al.
NATURE (2009)
Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2
Catherine P. A. Ivory et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
Guillaume Dalmasso et al.
GASTROENTEROLOGY (2008)
Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease
M. D. Bhavsar et al.
GENE THERAPY (2008)
Diagnostics of inflammatory bowel disease
Susanna Nikolaus et al.
GASTROENTEROLOGY (2007)
Mouse models of inflammatory bowel disease
Stefan Wirtz et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-β1-mediated suppression of colitis
Monica Boirivant et al.
GASTROENTEROLOGY (2006)
Cortistatin, an anti inflammatory peptide with therapeutic action in inflammatory bowel disease
E Gonzalez-Rey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
C Manichanh et al.
GUT (2006)
siRNA-based approaches in cancer therapy
G. R. Devi
CANCER GENE THERAPY (2006)
A phase I trial with Transgenic bacteria expressing interleukin-10 in Crohn's disease
Henri Braat et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Engineered E coli delivers therapeutic genes to the colonic mucosa
I Castagliuolo et al.
GENE THERAPY (2005)
Ginger - An herbal medicinal product with broad anti-inflammatory actions
R Grzanna et al.
JOURNAL OF MEDICINAL FOOD (2005)
Induction and suppression of RNA silencing: Insights from viral infections
O Voinnet
NATURE REVIEWS GENETICS (2005)
CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis
D Gao et al.
GUT (2005)
Rational siRNA design for RNA interference
A Reynolds et al.
NATURE BIOTECHNOLOGY (2004)
Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10
L Steidler et al.
NATURE BIOTECHNOLOGY (2003)
Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease
C Abad et al.
GASTROENTEROLOGY (2003)
Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis
JO Lindsay et al.
GUT (2003)
Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial
WJ Sandborn et al.
GASTROENTEROLOGY (2001)
Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa
A Lamprecht et al.
PHARMACEUTICAL RESEARCH (2001)
Inflammatory bowel disease: Immunodiagnostics, immunotherapeutics, and ecotherapeutics
F Shanahan
GASTROENTEROLOGY (2001)
Treatment of murine colitis by Lactococcus lactis secreting interleukin-10
L Steidler et al.
SCIENCE (2000)
Infliximab - A review of its use in the management of rheumatoid arthritis
A Markham et al.
DRUGS (2000)
Therapeutic effect of intracolonically administered nuclear factor κB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis
M Murano et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2000)
Immunobiology of vasoactive intestinal peptide (VIP)
D Pozo et al.
IMMUNOLOGY TODAY (2000)
Share Paper
